# Viking Therapeutics (VKTX) — Analyst Forecast

VKTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vktx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 18 | 2 | 0 | 20 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $65.00 | $88.00 | $114.00 | 3 |

Last price $27.37 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | $85.00 |
| Sep 23, 2026 | Truist Securities | Maintained | Buy | $87.00 |
| Aug 11, 2026 | JP Morgan | Maintained | Overweight | $65.00 |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | $114.00 |
| May 28, 2026 | Lake Street | Initiated Coverage | Buy | $89.00 |
| May 1, 2026 | BTIG | Maintained | Buy | $125.00 |
| Apr 30, 2026 | Cantor Fitzgerald | Maintained | Overweight | $100.00 |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | $102.00 |
| Nov 12, 2025 | Canaccord Genuity | Maintained | Buy | $107.00 |
| Oct 29, 2025 | Canaccord Genuity | Initiated Coverage | Buy | $106.00 |
| Oct 24, 2025 | JP Morgan | Maintained | Overweight | $75.00 |
| Oct 23, 2025 | Morgan Stanley | Maintained | Overweight | $102.00 |
| Sep 29, 2025 | HC Wainwright & Co. | Maintained | Buy | $102.00 |
| Sep 22, 2025 | BTIG | Maintained | Buy | $125.00 |
| Aug 19, 2025 | HC Wainwright & Co. | Maintained | Buy | $102.00 |
| Jul 24, 2025 | Citigroup | Maintained | Neutral | $38.00 |
| Jul 24, 2025 | Raymond James | Maintained | Strong Buy | $122.00 |
| Jun 25, 2025 | HC Wainwright & Co. | Maintained | Buy | $102.00 |
| Apr 28, 2025 | Truist Securities | Maintained | Buy | $75.00 |
| Apr 28, 2025 | Cantor Fitzgerald | Initiated Coverage | Overweight | $104.00 |

## Frequently Asked Questions

### What is the price target for VKTX stock?

The average 12-month analyst price target for Viking Therapeutics (VKTX) is $88.00, with a high estimate of $114.00 and a low of $65.00, across 3 analysts.

### Is VKTX a buy, sell, or hold?

Analysts covering Viking Therapeutics currently average a Buy rating: 18 buy, 2 hold and 0 sell, from 20 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for VKTX?

The average price target of $88.00 implies 221.52% upside from the last price of $27.37.

### What is the latest analyst rating on VKTX?

On Oct 7, 2026, Truist Securities maintained Viking Therapeutics at Buy with a price target of $85.00.

## Similar Stocks

- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [MDGL](https://www.lighthorse.io/tickers/mdgl) — Madrigal Pharmaceuticals, Inc. - Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).